TA104 Psoriatic arthritis, etanercept and infliximab - information for the public
The summary of the key recommendations of the technology appraisal on Psoriatic arthritis - etanercept and infliximab. It is written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets or any other suitable publication.
|
|
TA104 Psoriatic arthritis, etanercept and infliximab - information for the public
26 July 2006 (143.06 Kb 41 sec) |
